CELL INTELLIGENCE · 肿瘤细胞治疗研究

耳廓侵袭性细胞毒性淋巴瘤：一种未被充分认识的表现

Aggressive Cytotoxic Lymphomas of the Auricle: An Under-recognized Presentation.

原发性皮肤γδT 细胞淋巴瘤伴不寻常的临床病理特征：三例患者的分子特征研究

Primary Cutaneous Gamma-Delta T-Cell Lymphoma With Unusual Clinicopathological Characteristics: A Study of Three Patients With Molecular Characterizat

长期免疫抑制性皮肌炎并发的原发性皮肤γ-δ T 细胞淋巴瘤

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Complicating Long-Standing Immunosuppressed Dermatomyositis.

体外预处理维奈克拉可增强治疗性γδ T 细胞在 AML 模型中的抗白血病疗效

Ex vivo pretreatment with venetoclax boosts antileukemic efficacy of therapeutic γδ T cells in AML models.

原发性皮肤γδ T 细胞淋巴瘤的临床异质性：一项 20 年单中心经验

Clinical heterogeneity of primary cutaneous γδ T-cell lymphoma: a 20-year single-institution experience.

PCGDTCL 似乎表现出比以往认识到的更广泛的临床和治疗异质性。部分患者的持久缓解提示，治疗反应性可能在整个疾病谱中有所不同。

Elotuzumab 增强 Vγ9Vδ2 T 细胞对原发性渗出性淋巴瘤的抗肿瘤活性

Elotuzumab enhances the anti-tumor activity of Vγ9Vδ2 T cells against primary effusion lymphoma.

γδ T 细胞在血液病中的转化潜力：从免疫生物学到治疗创新

Translational potential of γδ T cells in hematologic diseases: from immunobiology to therapeutic innovation.

健康供者和慢性淋巴细胞白血病患者 B 细胞上 CD1d 和 ULBP3 的上调并不能使其易于被γδ T 细胞杀伤

Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells

反应性十二指肠活检中可检测到高度偏斜的 T 细胞受体免疫组化 αβ:γδ 比值：T 细胞淋巴瘤诊断中的潜在陷阱

Highly Skewed Immunohistochemical αβ:γδ Ratios for T-Cell Receptors Can Be Detected in Reactive Duodenal Biopsies: A Potential Pitfall in the Diagnosi

潜伏的米库伦新埃立克体感染可能在接受利妥昔单抗治疗的 B 细胞淋巴瘤患者中被重新激活

Latent Neoehrlichia mikurensis Infections May Be Reactivated in Patients With B-Cell Lymphomas Treated With Rituximab.